126 related articles for article (PubMed ID: 29331149)
1. Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells.
Di Gesù R; Bondì ML; Azzolina A; Craparo EF; Botto C; Amore E; Giammona G; Cervello M
J Nanobiotechnology; 2018 Jan; 16(1):3. PubMed ID: 29331149
[TBL] [Abstract][Full Text] [Related]
2. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.
Abdolahpour S; Toliyat T; Omidfar K; Modjtahedi H; Wong AJ; Rasaee MJ; Kashanian S; Paknejad M
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):89-94. PubMed ID: 28296511
[TBL] [Abstract][Full Text] [Related]
4. [Preparation of podophyllotoxin nanostructured lipid carriers and its effects on immortalized human cervical epithelial cells with HPV infection in vitro].
Chong SB; Zeng K; Li GF; Ren F; Zhu XL; Zhou JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1023-8. PubMed ID: 21690061
[TBL] [Abstract][Full Text] [Related]
5. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
[TBL] [Abstract][Full Text] [Related]
6. Correction: Chaperonin 60 sustains osteoblast autophagy and counteracts glucocorticoid aggravation of osteoporosis by chaperoning RPTOR.
Lian WS; Ko JY; Chen YS; Ke HC; Wu SL; Kuo CW; Wang FS
Cell Death Dis; 2019 Oct; 10(10):741. PubMed ID: 31582745
[TBL] [Abstract][Full Text] [Related]
7. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.
Luan J; Yang X; Chu L; Xi Y; Zhai G
J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
9. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
Wang Z; Wang J; Yang S; Hou S
Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
[TBL] [Abstract][Full Text] [Related]
10. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
[TBL] [Abstract][Full Text] [Related]
13. Correction to: MKK4/MKK5‑MPK1/MPK2 cascade mediates SA‑activated leaf senescence via phosphorylation of NPR1 in Arabidopsis.
Zhang J; Zhu Z; Song Y; Wang X; Wang X; Zhou X; Gao J; Kuai B
Plant Mol Biol; 2020 Sep; 104(1-2):217. PubMed ID: 32661661
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
Beloqui A; Solinís MÁ; Rodríguez-Gascón A; Almeida AJ; Préat V
Nanomedicine; 2016 Jan; 12(1):143-61. PubMed ID: 26410277
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Minichromosome Maintenance (MCM) family as potential diagnostic and prognostic tumor markers for human gliomas.
Hua C; Zhao G; Li Y; Bie L
BMC Cancer; 2019 Mar; 19(1):260. PubMed ID: 30902079
[TBL] [Abstract][Full Text] [Related]
17. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
18. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
Silva AC; Santos D; Ferreira DC; Souto EB
Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies.
Gadhave DG; Kokare CR
Drug Dev Ind Pharm; 2019 May; 45(5):839-851. PubMed ID: 30702966
[TBL] [Abstract][Full Text] [Related]
20. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
